Endocrine Cancers SIG

May 02, 2022

Discuss advancements in understanding and treating endocrine cancers and collaborate with colleagues on the best avenues for care. By becoming a member of the Endocrine Cancers SIG, you will be the first to know about the SIG’s educational content and networking activities. Sign up today! View the Endocrine Cancers leadership roster. 


Past Events

Endocrine Cancers SIG held a webinar on the diagnosis, surgical management, and latest therapies for anaplastic thyroid cancer. This event was held April 27, 2022.

Learning Objectives

  • 1. Describe the important tests for diagnosing and staging anaplastic thyroid cancer.

  • 2. Identify important factors for the optimal surgical management of anaplastic thyroid cancer.

  • 3. Describe evidence-based therapies for anaplastic thyroid cancer.


  • Electron Kebebew, MD, FACS, Harry A. Oberhelman Jr and Mark L. Welton Professor and Chief of General Surgery, Stanford University Health

  • Maria Cabanillas, MD, Oncologic Endocrinologist University of Texas MD Anderson Cancer Center


  • Zeina Hannoush, MD Assistant Clinical Professor University of Miami Health System

  • Samira Sadowski, MD Physician-Scientist Early Investigator National Cancer Institute, Center for Cancer Research

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.